SCHEMBL1093124

SCHEMBL1093124

CC(C)[Si](OC1CCN(N2CC[C@@H](Cc3c(Cl)cc(-c4ccc(C(=O)N5CCC(F)(F)CC5)cc4)cc3Cl)C2=O)CC1)(C(C)C)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FASN P49327 2/20 0.37
LRRK2 Q5S007 1/20 0.35
HTR1A P08908 4/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PDE5A O76074 1/20 0.34
PDE4A P27815 1/20 0.34
PDE1A P54750 1/20 0.34
PDE1B Q01064 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
PDE7A Q13946 1/20 0.34
PDE1C Q14123 1/20 0.34
PDE3A Q14432 1/20 0.34
PDE7B Q9NP56 1/20 0.34
HRH3 Q9Y5N1 4/20 0.34
HRH1 P35367 2/20 0.34
CCR3 P51677 2/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1093126 1.00 FASN (0.37) FASNLRRK2HTR1AMEN1KMT2A
SCHEMBL1091733 0.92 LRRK2 (0.35) FASNLRRK2HTR1AMEN1KMT2A
SCHEMBL1091734 0.92 LRRK2 (0.35) FASNLRRK2HTR1AMEN1KMT2A
SCHEMBL1092806 0.90 ALDH1A1 (0.41) LRRK2KMT2AHRH3HRH1MET
SCHEMBL1092804 0.90 ALDH1A1 (0.41) LRRK2KMT2AHRH3HRH1MET
SCHEMBL1091982 0.90 HTR2B (0.34) FASNMEN1KMT2AHRH3HRH1
SCHEMBL1091979 0.90 HTR2B (0.34) FASNMEN1KMT2AHRH3HRH1
SCHEMBL209468 0.88 FASN (0.37) FASNLRRK2HTR1AMEN1KMT2A
SCHEMBL209466 0.88 FASN (0.37) FASNLRRK2HTR1AMEN1KMT2A
SCHEMBL209467 0.88 FASN (0.37) FASNLRRK2HTR1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153807-B2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-04-10 US disclosed
EP-2021336-B1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2010-06-30 EP disclosed
US-20090111809-A1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 BUSH JULIE KAY 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111809-A1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD3B1, HSD11B2 FASN 100/4885LRRK2 3710/4885HTR1A 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.